Category Archives: Health

Aster DM Healthcare announces a Large Special Dividend of Rs.118/- per share to its shareholders.

15th April 2024, Bengaluru: The Board of Directors at Aster DM Healthcare Limited (“Company”), one of the largest integrated healthcare providers in India, has announced a Large Special Dividend of Rs.118/- per share on account of the receipt of proceeds from the sale of the GCC business. The special dividend will be paid within 30 (thirty) days from the date of the declaration i.e. April 23, 2024. This event will result in a significant distribution of ~80% of the consideration of USD 907.6 million as a dividend to its shareholders. Despite this large special dividend, the company will still retain INR~1500 Cr from the sale of GCC business in the reserves under its balance sheet.

The Company had recently concluded the separation of its India and GCC businesses, pursuant to which Affinity Holdings Limited (a wholly subsidiary of the Company) received a cash consideration of USD 907.6M.

The Moopen family continues to hold the 41.88% stake in the listed entity. Dr. Azad Moopen will remain the Founder Chairman and Ms. Alisha Moopen will remain a director on the board of the Company. The listed entity will be led by Dr. Nitish Shetty as Chief Executive Officer, who will focus on the growth of the India business, aimed at creating value for its shareholders.

Dr. Azad Moopen, Founder Chairman, Aster DM Healthcare said, “The current Indian healthcare market looks promising and post segregation now, our efforts will be to dynamically increase our footprint in India. We are making the right investments in our people, innovation, and infrastructure to differentiate ourselves and create long-term value for all our stakeholders. The dividend to be paid is proof of our commitment to all shareholders. As the company progresses, it will continue to prioritize shareholder interests and make decisions in their best interest towards creating sustained long-term value.”

Dr. Nitish Shetty, CEO, Aster DM Healthcare, India said, “The last quarter saw us make significant progress in many aspects, demonstrating our execution strength. We aim to balance shareholder returns with future investments for sustained long-term growth. The dividend distribution plan aims to reward shareholders for their long-held trust and investment in the company. Aster DM Healthcare remains committed to transparency and regulatory compliance throughout the process.”

As the Indian entity is now separate from its GCC counterpart, the Company plans to add 1700 beds by FY27 through the organic route and will further look for expansion through the inorganic route as well. Through both greenfield and brownfield opportunities, the company aims to take its total bed tally in India to 6600+ in the next 3 years and scale up its labs and pharmacy business to emerge as the top 3 integrated healthcare providers in India. The plan will encompass a mix of brownfield and greenfield projects, including the upcoming Aster Capital in Trivandrum, and Aster MIMS Kasargod, and adding bed capacity to the existing hospitals. The Company will also be looking at potential markets such as Maharashtra and Uttar Pradesh. The capital allocation for this expansion is in the range of 1000cr.

Groundbreaking QT Breast Imaging Technology

El Dorado Hills, CA, April 12, 2024 — True Health Center for Precision Medicine is proud to announce the integration of state-of-the-art QT imaging technology into its renowned breast imaging facility, Qlarity Breast Imaging, located in El Dorado Hills, CA. This pioneering advancement marks a significant leap forward in the field of precision medicine, offering patients unparalleled accuracy and efficacy in breast health diagnostics.

QT imaging technology represents the latest innovation in medical imaging, providing enhanced clarity and precision in the detection and diagnosis of breast cancers. QT offers radiologists and healthcare providers unparalleled insight into breast tissue composition, enabling early detection of potential breast cancer with unprecedented accuracy.

“At True Health Center for Precision Medicine, we are committed to pushing the boundaries of healthcare innovation to provide our patients with the highest standard of care,” said Kristine Burke, MD, Founder and Medical Director of True Health Center for Precision Medicine. “The integration of QT technology into our Qlarity Breast Imaging facility underscores our dedication to leveraging cutting-edge advancements to revolutionize breast health diagnostics.”

The implementation of QT technology at Qlarity Breast Imaging enables local women and surrounding communities to access the most advanced breast imaging services available. With its ability to detect subtle changes in breast tissue composition just months apart, QT facilitates earlier detection of breast cancer, ultimately leading to more effective treatment outcomes and improved patient prognosis.

True Health Center for Precision Medicine invites patients and healthcare providers in the El Dorado Hills area to experience the transformative capabilities of QT imaging technology at Qlarity Breast Imaging. With its unparalleled accuracy and precision, QT represents a significant advancement in the early detection and diagnosis of breast cancers, ultimately improving patient outcomes and advancing the standard of care in breast health.

Awareness Session on World Parkinson’s Day at MGM Healthcare

Chennai, 12th April 2024 – In commemoration of World Parkinson’s Day, MGM Healthcare, a multi-speciality quaternary care hospital in the heart of Chennai, conducted a highly informative and impactful awareness session aimed at educating the public about Parkinson’s disease. The event was conducted at MGM Healthcare with participation by neurology experts Dr. U.Meenakshisundaram, Director and Senior Consultant, Department of Neurology, MGM Healthcare, and Dr.Sreenivas U.M., Consultant, Department of Neurology, MGM Healthcare, along with Ms. Vijayshree, Chief Dietician, Department of Dietetics, MGM Healthcare and Dr. Rajendran AJ, Clinical Lead, Dept of Rehabilitation Medicine, MGM Healthcare to shed light on this disorder and how to cope with it.

Parkinson’s disease affects millions of people worldwide, with a rising incidence in India. Raising awareness about the disease, including its symptoms, mode of diagnosis, and treatment options is crucial. The awareness session was presented by renowned neurologists from MGM Healthcare, who shared insights into the latest advancements in Parkinson’s research, treatment options, and strategies for improving the quality of life for patients.

The awareness session also highlighted the importance of early detection, proper medication adherence, and the role of physical therapy and lifestyle modifications in managing the symptoms of Parkinson’s.

The Welcome address for the Parkinson’s awareness day was delivered by Dr. U.Meenakshisundaram, Director and Senior Consultant, Department of Neurology, MGM Healthcare, following which a yoga exercise session was conducted, to help people with Parkinson’s to improve their balance and mobility.

Dr.Sreenivas U.M., Consultant, Department of Neurology, MGM Healthcare, presented a short insight about the Parkinson’s Disease, including recent research and treatment developments. This was followed by a session on Nutrition for Parkinson’s by Ms. Vijayashree, Chief Dietician, Department of Dietetics, MGM Healthcare.

The last session was on Innovative Exercise Methods for Parkinson’s Management by Dr. Rajendran AJ, Clinical Lead, Dept of Rehabilitation Medicine, MGM Healthcare, which

Dr. U.Meenakshisundaram, Director and Senior Consultant, Department of Neurology, MGM Healthcare shared his thoughts on the awareness program: “MGM Healthcare is honoured to contribute towards raising awareness about this challenging neurological condition. Through our awareness session, we aim to empower the patients with knowledge and support about Parkinsons. We believe that together, we can make a difference in the lives of those affected by Parkinson’s disease.”

As part of its ongoing commitment to neurological care, MGM Healthcare plans to continue organizing educational initiatives and support programs for patients affected by Parkinson’s disease.

T-Medical Group Inc.’s Subsidiary 365Telamind

New York, NY, April 11, 2024 — T-Medical Group Inc., a pioneering force in the healthcare solutions industry, today announced that its wholly-owned subsidiary, 365Telamind, is set to sponsor an exclusive women’s mental health empowerment event on April 28, 2024, from 3 pm to 7 pm in Westbury, New York. This groundbreaking initiative aims to foster a deeper understanding of the unique mental health challenges faced by women while inspiring them to embrace their inherent strengths and unleash their full potential.

At the core of this transformative event lies a profound belief in the power of open dialogue and the promotion of mental well-being among women from all walks of life. In line with this vision, the event will feature renowned speakers and thought leaders who will delve into the multifaceted aspects of women’s mental health, underscoring the critical need for compassionate understanding and robust support systems within our communities.

Headlining the event will be Dr. Lena G. Clark, the esteemed CEO of T-Medical Group Inc., and Quenton “QdaBoss” Brown, the event organizer and founder of Empowered Dynasty a highly acclaimed motivational speaker and mental health advocate. These exceptional figures will share their invaluable insights, inspiring attendees to embrace self-acceptance, resilience, and the pursuit of personal growth.

“As a society, we must actively work towards supporting and lifting up one another, particularly when it comes to mental health matters,” Dr. Lena G. Clark passionately expressed. “By facilitating open discussions and providing valuable resources, we can cultivate an atmosphere of inclusivity wherein every woman feels seen, heard, and appreciated.”

Attendees of the event can expect an immersive and transformative experience that transcends traditional lectures. They will have the unique opportunity to interact with experts, connect with fellow participants who share a passion for mental health advocacy, and partake in thought-provoking activities designed to ignite personal growth and foster lasting change.

“We are thrilled to host this groundbreaking event and contribute to the ongoing conversation surrounding women’s mental health,” said Dr. Lena G. Clark, CEO of T-Medical Group, Inc. “By bringing together influential voices and creating a safe space for dialogue, we aim to empower women to embrace their authentic selves and forge a path towards collective healing and empowerment.”

This exclusive event promises to be a catalyst for positive change, igniting a movement that celebrates the resilience and strength of women while promoting mental well-being as a fundamental human right. Don’t miss this extraordinary opportunity to learn, grow, and forge meaningful connections with those who share your dedication to enhancing women’s mental health. Mark your calendars for April 28, 2024, and join them in shaping a brighter future for all.

Boiron’s Wellness Kits Offer Holistic Approach to Pain Management

Newtown Square, PA, April 11, 2024 –Boiron, world leader in homeopathic medicines, introduces its new Arnicare Wellness Kits as convenient and comprehensive solutions for painsleep and stress relief. The kits are designed to provide individuals with daytime and nighttime options to manage pain with occasional sleeplessness and symptoms of stress.

“Pain can often lead to frequent nighttime awakenings, disrupting sleep patterns and causing discomfort,” said Ken Redcross, a board-certified internal medicine physician. He said research indicates those who experience poor or insufficient sleep are more likely to report higher levels of pain sensitivity, creating a challenging cycle that hampers well-being. Additionally, stress can also heighten the perception of pain and contribute to sleeplessness.

“Many individuals actively search for solutions to address pain, sleep, and stress symptoms which are all interconnected so they can better manage their pain which enhances their overall well-being,” Dr. Redcross said.

“I always advise my patients to consider ‘closer to the earth’ remedies, such as homeopathic medicines, which carry a very low risk of side effects and can be safely used alongside other treatments,” he continued, noting that many people may resort to taking multiple medications when addressing these concerns.

Included in the kits is Arnicare Cream, formulated with Arnica to relieve muscle pain and stiffness, swelling from injuries, and bruises.* To complement the cream, the kits contain either melatonin-free SleepCalm® Meltaway Tablets for night use or StressCalm® Meltaway Tablets for daytime. SleepCalm offers a non-habit forming solution to relieve occasional sleeplessness, restless sleep, and intermittent awakening.* For daytime use, StressCalm provides non-drowsy relief for occasional nervous tension, irritability, hypersensitivity, and fatigue due to everyday stress.*

Ombra Group Acquires 75% of IUT Medical GmbH

New York, NY, April 11, 2024 –Ombra Group Inc, a global pioneer in advanced technology solutions, today announced its acquisition of IUT Medical GmbH, a world-renowned German company specializing in cutting-edge gas and hazardous chemical detection systems. Founded in 1998 by the late Prof. Dr. Jürgen Leonhardt, IUT Medical has solidified its reputation as an industry leader, delivering unparalleled accuracy and reliability to clients across the globe.

This strategic move underscores Ombra Group’s commitment to the rapidly evolving environmental and industrial safety market, forecasted to reach a staggering US $60 billion by 2030, according to a comprehensive report by MarketsandMarkets Research. A key driver behind the acquisition is Ombra Group’s ambition to harness IUT Medical’s pioneering breath analysis technology for detecting controlled substances such as fentanyl, methamphetamine, and tetrahydrocannabinol (THC). Additionally, the combined entity aims to empower law enforcement agencies worldwide with advanced solutions for identifying and dismantling clandestine drug production facilities.

By integrating IUT Medical’s decades of expertise in gas and chemical detection with Ombra Group’s cutting-edge artificial intelligence (AI) and software engineering capabilities, the two companies are poised to usher in a new era of innovation within the public health and safety sector. This powerful synergy will catalyze the development of next-generation detection solutions that are not only more intelligent and efficient but also unprecedented in their accuracy and reliability.

“Acquiring IUT Medical is a strategic move that will propel our future product development initiatives to new heights,” said Dominick Bianco, CEO of Ombra Group. “Their superior detection technology, coupled with our proficiency in AI and software, creates a formidable foundation for introducing ultra-intelligent solutions that will redefine industry standards. We are excited to combine our respective strengths and unlock the full potential of IUT Medical’s groundbreaking systems.”

The acquisition promises to yield significant benefits for both companies and their respective customers:

Heightened Product Value: By seamlessly integrating Ombra Group’s AI and software capabilities into IUT Medical’s existing suite of detection systems, the combined entity will deliver smarter, more efficient, and highly competitive solutions that cater to the evolving needs of the market.

Accelerated Technological Advancements: The collective knowledge, resources, and expertise of these two industry leaders will fuel the rapid development of novel, high-tech gas and chemical detection devices, solidifying their position at the forefront of innovation.

Enhanced Operational Efficiencies: By streamlining operations and leveraging shared resources, the combined entity will benefit from increased operational efficiencies, enabling faster time-to-market for new products and solutions.

Expanded Global Reach: Leveraging Ombra Group’s management and extensive global footprint, IUT Medical’s cutting-edge products will gain access to new markets and customer segments across diverse environmental and industrial safety domains.

“This acquisition marks a significant milestone for IUT Medical and a testament to Prof. Leonhardt’s enduring legacy,” stated Franz Finsch, spokesperson for IUT Medical. “Joining forces with Ombra Group ensures the continued growth and evolution of our cutting-edge detection technologies, while providing us with the resources and expertise to tackle some of the most pressing challenges in the realms of illegal drug production and use. We are excited to embark on this new chapter and seize the myriad opportunities that lie ahead in the rapidly expanding gas and chemical detection market.”

Answers by Dr. S.A. Rehman, General Medicine, Associate Prof. Noida International Institute of Medical Sciences and Hospital, NIU

By Dr. S.A. Rehman, General Medicine, Associate Prof. Noida International Institute of Medical Sciences and Hospital, NIU

What do tongue colors reveal about health?
The color of the tongue can provide vital information about general health. Here’s a breakdown of what varied tongue colors could imply about health:
1. Pink: A healthy tongue is usually pink, with a thin white coating. This signifies proper circulation and overall health.
2. White Coating: A thick white layer on the tongue may indicate oral thrush (a fungal infection), dehydration, or poor oral hygiene.
3. Red or Strawberry Tongue: A vivid red or strawberry-like look could indicate a vitamin deficiency, Kawasaki disease in children, or scarlet fever.
4. Yellow Coating: A yellowish coating may indicate liver or gallbladder issues, jaundice, or stomach problems.
5. Blue or Purple Tongue: A bluish or purple discoloration may suggest poor circulation, oxygen deprivation, or cyanosis, which can be a sign of underlying health conditions such as heart or lung problems.

What is considered a normal tongue color?
Normal Tongue Color: A healthy tongue is usually pink with a thin white covering. This signifies proper circulation and overall health.

What does it mean to have a black hairy tongue?
Black Hairy Tongue: This ailment arises when the microscopic bumps on the surface of the tongue grow larger, resulting in a black, hairy look. It is frequently caused by poor dental hygiene, smoking, excessive alcohol consumption, or certain drugs. While it may appear alarming, it is mostly harmless and can be managed by improving dental hygiene and treating underlying problems.

Other tongue colors that could be concerning?
Other Concerning Tongue Colors:

• – White Coating: A thick white layer on the tongue may indicate oral thrush (a fungal infection), dehydration, or poor oral hygiene.
• – Red or Strawberry Tongue: A bright red or strawberry-colored tongue could indicate a vitamin deficiency, Kawasaki disease in children, or scarlet fever.
• – Yellow Coating: A yellowish coating on the tongue may indicate liver or gallbladder difficulties, jaundice, or stomach problems.
• – Blue or Purple Tongue: A bluish or purple tint on the tongue may indicate poor circulation, oxygen deprivation, or cyanosis, all of which can be symptoms of underlying health conditions such as heart or lung difficulties.

While changes in tongue color might provide health hints, they should be addressed in conjunction with other symptoms and medical history to ensure an appropriate assessment. If you detect any persistent changes in the color or texture of your tongue, you should speak with a healthcare professional for an accurate diagnosis and treatment.

FuseBio Presents New Data at AACR

Woburn, MA, April 10, 2024 — Fuse Biotherapeutics, Inc., a biotechnology company developing functionally-selective cytokines for cancer and autoimmune disease, today announced the presentation of new data with respect to their lead asset PD1-F18, at the American Association for Cancer Research (AACR) Annual Meeting being held on April 5-10, 2024, in San Diego, CA. The Fuse Biotherapeutics team will present data on April 9, 2024 that strongly supports the use of PD1-F18 as a highly differentiated PD-1 targeted IL-18 with first and best in class potent single agent antitumor activity.

FuseBio has leveraged its immuno-oncology and protein engineering capabilities to functionally optimize IL-18 (F-18), creating an IL-18 binding protein-resistant molecule with 1 million percent reduced activity in circulation while retaining nearly full affinity for the IL-18 receptor complex when targeted to an immune cell of interest. F-18 was fused onto a PD-1 inhibitor to create a first-in-class PD1-F18 immunocytokine designed for full PD-1 checkpoint blockade while safely delivering IL-18.

“A tremendous amount of effort was made to design a therapeutic to overcome resistance to PD-1 inhibitors such as Keytruda,” said Brian Rabinovich, Ph.D, Chief Scientific Officer of Fuse Biotherapeutics. “Since the immune cells that remain functional and kill tumors in response to PD-1 inhibitors preferentially express the receptor complex for IL-18, the safe and selective delivery of F18 to these cells not only augments their anti-tumor capabilities but also preserves their capacity to respond to a the drug class that placed immunotherapy firmly on the cancer treatment map.” Jeff Takimoto, Ph.D, the Chief Executive Officer of Fuse Biotherapeutics continued, “That we are able to abolish aggressive and PD-1 inhibitor resistant tumors in animal models without side effects is an incredible achievement for our team. We are excited to embark on moving PD1-F18 to the clinic and view our finding as providing much needed hope for the more than 80% of cancer patients that are either resistant or become resistant to PD-1 inhibitors.”

Enhanced rock weathering results in higher crop yields and improved crop health

Enhanced rock weathering – a nature-based carbon dioxide removal process that accelerates natural weathering – results in significantly higher first-year crop yields, improved soil pH, and higher nutrient uptake, according to a new scientific paper, released in PLOS ONE today.

Enhanced rock weathering (ERW) involves spreading finely crushed silicate rock such as basalt on agricultural land. It is a scalable and permanent climate technology with the potential to sequester gigatonnes of carbon dioxide from the atmosphere. Co-authored by scientists at UNDO, a leading enhanced rock weathering project developer, and Newcastle University, the peer-reviewed publication is the latest enhanced rock weathering (ERW) study assessing the impact on crops in a temperate climate.

Dr XinRan Liu, Head of Science and Research at UNDO and co-author of the paper, commented: “Nutrient limitations in agricultural soils are a major concern for farmers about sustaining and increasing crop yields. This latest study highlights how the spreading of basalt rock on farmland can lead to higher crop yields and can be effective in a temperate climate. This research demonstrates the potential for enhanced rock weathering to contribute to improved farmer livelihoods and food production, whilst also removing CO2 from the atmosphere.”

The results from the ongoing trial’s first year demonstrate that the crop yield was on average 15% higher (9.3% and 20.5% between plowed and direct drill amended plots respectively) across two different cultivation techniques.

The trial results also showed a stabilizing effect on the soil pH, with the soil pH being on average 0.2 and 0.29 pH units higher in the basalt-amended plots, compared to the control plots. This change is a result of alkaline products generated as the rock minerals dissolve. The effect of silicate mineral dissolution on the soil pH could represent an attractive agronomic benefit for farmers as an elevated soil pH allows crops to access more nutrients in the soil.

Basalt rock is rich in minerals that slowly release nutrients during dissolution. These nutrients act as a natural soil amendment and are essential for plant growth. The study found higher nutrient concentrations in the crops grown in the basalt-amended soil, including tissue calcium, grain, and tissue potassium, suggesting that ERW can boost nutrient availability for plants and, as a result, may improve crop yield.

Taking account of the unusually dry growing season conditions in 2022, these findings indicate that basalt amendment could enhance productivity and crop yields, contributing to more sustainable and resilient food production systems in the face of future changes in growing season weather as a result of global warming.

Professor David Manning, Professor of Soil Science, Newcastle University, and co-author of the paper, commented: “The results of this trial give further scientific credibility for enhanced rock weathering and greatly improve its value proposition to farmers. Newcastle University is pleased to partner with UNDO. Our joint research into the co-benefits for farmers of basalt amendment is helping to pave the way for the widespread adoption of enhanced rock weathering in the agricultural community.”

The trial results also show no additional toxic elements taken up by crops in the plots where basalt had been spread. There was no negative impact on the natural environment in this trial, which indicates the food produced from it is safe for consumption. UNDO’s basalt has been approved for use in organic farming systems by respected certification bodies such as the Soil Association.

Yit Arn Teh, Professor of Soil Science, Newcastle University, said: “Independent bodies, such as the IPCC and UK Committee for Climate Change, have repeatedly highlighted the urgent need for climate action in the agriculture and land use sector to counter the effects of dangerous climate change. At the same time, the agricultural sector is under increasing pressure to meet key sustainability and environmental targets, against a backdrop of rising farm operating costs, driven by the cost of living crisis.

“Use of enhanced rock weathering to remove carbon dioxide and naturally enhance soil health represents a potential win-win for farmers and climate as this technology is able to capture carbon dioxide while simultaneously supplying some of the key nutrients that crops require for successful growth. By using locally-sourced rocks, rather than inputs (e.g. fertilizers) obtained from overseas, supply chains are also shortened, further reducing the overall carbon footprint of food production.

“Crucially, enhanced rock weathering is a technology that can be readily adopted by the agricultural sector because it does not require farmers to invest in new equipment, technology or training, but simply utilizes the existing equipment and infrastructure for spreading fertilizer or other soil amendments.”

The authors of the paper hope that the agronomic co-benefits of enhanced rock weathering will further incentivize farmers across the UK and worldwide to take advantage of this nature-based carbon removal solution.

Sakra World Hospital Successfully Performs 100 Robotic GI Surgeries, Enhances Patient Outcomes

Bengaluru 9th April 2024: Sakra World Hospital, a pioneering healthcare facility in India funded entirely by foreign direct investment (FDI), has completed 100 robotic gastrointestinal (GI) surgeries. In the medical field, robotic-assisted surgical procedures are steadily on the rise. The increasing acceptance of robotic surgeries can be attributed to their accuracy, minimally invasive techniques, and capacity to improve surgical outcomes. With a group of skilled surgeons and cutting-edge facilities, Sakra World Hospital has become a pioneer in leveraging this technology to help patients suffering from gastrointestinal surgical issues.

Robotic-assisted surgery enables the performance of intricate procedures across a wide spectrum, including colorectal cancers, and benign and malignant conditions of the liver, biliary system, and pancreas, apart from complex hernia repairs, gallbladder removals, and abdominal wall reconstruction. With a focus on less trauma and greater precision in these surgical interventions, Sakra tremendously benefits patients specializing in upper gastrointestinal surgeries, such as giant hiatal hernias, gastroesophageal reflux disease (GERD), Heller’s myotomy, and even uncommon conditions like median arcuate ligament syndrome.

“We take immense pride in reaching a significant milestone in robotic GI surgeries, underscoring the skill and commitment of our proficient surgical team,” lauded Lovekesh Phasu, Chief Operating Officer, Sakra World Hospital, Bengaluru, adding, “At Sakra, we’re committed to setting high standards and achieving them, to benefit our patients and provide quality healthcare for all.”

The application of robot-assisted technologies has greatly improved surgical capabilities in GI surgeries. These systems are operated directly by surgeons, in contrast to autonomous systems, which enable careful dissection around target organs. Although laparoscopic surgery provides benefits such as accurate dissection under high-resolution imaging and minimally invasive procedures, it has limitations due to the limited dexterity of the instruments. These limitations are overcome by the existing robotic system’s articulated instruments, vibration filtering, and motion scaling functions. These capabilities allow surgeons to perform more versatile surgeries than they could with standard laparoscopic equipment.

Moreover, the robotic system’s instruments with wrist-like movements and dexterity assures delicate tissue handling and precision surgery with minimal bleeding. This capability, coupled with three-dimensional magnified, enhanced imaging, provides a platform wherein complex procedures in critical places and organs can be safely performed. Through these innovations, robotics surgery in the gastrointestinal realm continues to push boundaries, enhancing surgical precision and expanding treatment options for patients.

Robotic GI surgery has emerged as a reassuring alternative to traditional methods, dispelling common fears. The robotic system not only provides surgeons with better visualization and precision, but the patient also benefits from smaller incisions, less blood loss, quicker recovery, and reduced post-operative pain.

“The completion of 100 robotic GI surgeries at Sakra World Hospital not only marks a numerical achievement but also serves as evidence of the hospital’s steadfast dedication to delivering top-notch care to its patients,” remarked Dr Sadiq Saleem Sikora, Director of Gastrointestinal Surgery and Liver Transplantation at Sakra World Hospital, Bengaluru.